DealsJun 29, 2026, 04:32 PM
Schrodinger receives $57M cash from Eli Lilly's Ajax acquisition
AI Summary
Schrodinger, Inc. received a cash payment of approximately $57 million following the completion of Eli Lilly and Company's acquisition of Ajax Therapeutics, Inc. Schrodinger had co-founded Ajax Therapeutics. The company is also eligible for additional cash payments contingent on Ajax achieving specific clinical and regulatory milestones.
Key Highlights
- Received approximately $57 million in cash payment.
- Payment is from Eli Lilly and Company's acquisition of Ajax Therapeutics, Inc.
- Schrodinger, Inc. co-founded Ajax Therapeutics, Inc.
- Eligible for additional cash payments based on clinical and regulatory milestones.
Price Impact
More from SDGR